Evolocumab to reduce cardiovascular events: results of the (FOURIER) multinational trial

Syed Raza Shah, Mohd Faisal Uddin, Noman Lateef, Amin Muhammad Dharani, Waqas Shahnawaz, Ahmed Kazi, Syed Arbab Shah, Syed Arbab Shah

Journal of Community Hospital Internal Medicine Perspectives · 2017 · 11 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

Dear Sir,Proprotein convertase subtilisin-kexin type 9 (PCSK9) is a protease that binds to the extracellular compartment of the LDL receptor, hence, targeting the LDL receptor to the lysosomal comp...

References

5